L-Carnitine Tartrate

L-Carnitine Tartrate is a synthesised form of the amino acid L-Carnitine, produced by combining L-Carnitine with tartaric acid. It plays a central role in cellular energy metabolism by shuttling long-chain fatty acids across the mitochondrial membrane, where they are oxidised to produce ATP. This makes it a well-known ingredient in sports nutrition, energy support, and healthy ageing product categories.

Brands use L-Carnitine Tartrate in gummy formats because it is heat-stable, soluble, and has a good sensory profile when properly masked. It is one of the most familiar and commercially understood gummy actives across EU and US markets, with strong consumer awareness in the sports and active lifestyle segment. Its mid-cost tier makes it accessible for both white-label and custom development projects.

Origin and history

L-Carnitine was first isolated from meat extracts in 1905 by Russian chemists Gulewitsch and Krimberg. The name derives from the Latin "carnus" (flesh), reflecting its natural abundance in red meat. The L-isomer is the biologically active form, and L-Carnitine Tartrate is the most common salt form used in dietary supplements due to its stability and solubility.

Industrial production of L-Carnitine Tartrate is achieved through chemical synthesis or fermentation, with the tartrate salt formed by reacting L-Carnitine with L-tartaric acid. The manufacturing process yields a white crystalline powder that is odourless and stable under standard conditions. DAT sources L-Carnitine Tartrate from qualified suppliers with full traceability documentation.

Scientific overview

L-Carnitine functions as a carrier molecule in the mitochondrial membrane, facilitating the transport of activated long-chain fatty acids into the mitochondrial matrix for beta-oxidation. This process is essential for energy production from fat stores, particularly during exercise and periods of increased metabolic demand. The body synthesises L-Carnitine from lysine and methionine, but dietary intake and supplementation can support optimal levels.

Bioavailability of L-Carnitine Tartrate is well-established, with absorption occurring primarily in the small intestine via active transport. The tartrate salt form offers improved stability and solubility compared to the free base, making it suitable for gummy formulations. Doses typically range from 500 mg to 3000 mg per serving, with higher doses associated with the fishy odour note from trimethylamine production.

Manufacturing watchpoints include the slight fishy/meat-like taste that requires masking in gummy formats. Heat stability is good, and solubility in gummy matrices is acceptable, though payload constraints per gummy weight must be considered. The mid-cost tier means it is economical for mass-market positioning but requires careful formulation to maintain sensory quality.

L-Carnitine Tartrate occupies a strong position in the sports nutrition and active lifestyle segment, where consumer awareness is high. It is one of the most familiar and commercially understood gummy actives across EU and US markets, with established demand in energy, recovery, and weight management categories. Brands use it to differentiate their gummy ranges from standard multivitamin offerings, targeting fitness-conscious consumers who prefer gummy formats over capsules or powders.

From a formulation perspective, L-Carnitine Tartrate is heat-stable and soluble, making it practical for gummy manufacturing. The main challenge is the slight fishy/meat-like taste, which requires effective masking through fruit flavours and sweetener systems. Payload constraints mean that achieving the typical 500–1000 mg dose per serving may require multiple gummies or larger gummy weights. DAT reviews formulation feasibility per project.

Pack-copy guidance: L-Carnitine has no authorised EU health claims under Reg. 432/2012. Brands should position via co-formulated nutrients such as Vitamin B6, B12, or Magnesium for energy-yielding metabolism claims, or use non-claim brand messaging around energy support and sports recovery. No disease claims are permitted. DAT reviews claim strategy and compliance per project.